FDA Approved: CEFPROZIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for cefprozil from Lupin Pharmaceuticals, Inc., resulting in updated labeling under the supplemental submission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchitis
• Otitis Media
• Pharyngitis
• Sinusitis
• Skin and Soft Tissue Infections
• Tonsillitis

Drugs mentioned

• Cefprozil (cefprozil)

Snippet

SUPPL AP for CEFPROZIL (CEFPROZIL)